Cytori to Webcast First Quarter Financial Results May 9
APR 27, 2012 - 08:00 ET
FOR: CYTORI THERAPEUTICS, INC.
SAN DIEGO, CA--(Marketwire - April 27, 2012) - Cytori Therapeutics (
The dial-in information is as follows:
Dial-In Number: +1.888.208.1815
Prior to the webcast at approximately 4:05 PM Eastern Time on May 9, Cytori will issue its first quarter earnings release and post a quarterly shareholder letter to its Investor Relations homepage, which will review Cytori's first quarter performance.
The webcast will be available both live and by replay two hours after the call on the Company's website, under "Webcasts" on the Investor Relations page (http://ir.cytoritx.com).
Cytori Therapeutics is developing cell therapies based on autologous adipose-derived regenerative cells (ADRCs) to treat cardiovascular disease and repair soft tissue defects. Our scientific data suggest ADRCs improve blood flow. As a result, we believe these cells can be applied across multiple "ischemic" conditions. These therapies are made available to the physician and patient at the point-of-care by Cytori's proprietary technologies and products, including the Celution® System product family. www.cytori.com